Field Trip Health Ltd
TSX:FTRP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Field Trip Health Ltd
TSX:FTRP
|
CA |
|
N
|
NPC Resources Bhd
KLSE:NPC
|
MY |
|
Achilles Corp
TSE:5142
|
JP |
|
Arch Capital Group Ltd
NASDAQ:ACGL
|
BM |
|
Schneider Electric SE
OTC:SBGSF
|
FR |
|
Piedmont Lithium Inc
NASDAQ:PLL
|
US |
|
B
|
Bullfrog AI Holdings, Inc.
NASDAQ:BFRG
|
US |
|
S
|
Schlumberger NV
PAR:SLB
|
US |
|
A
|
Ads Maritime Holding Plc
OSE:ADS
|
NO |
|
R
|
RACL Geartech Ltd
BSE:520073
|
IN |
|
Parsons Corp
NYSE:PSN
|
US |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
Morella Corporation Ltd
ASX:1MC
|
AU |
|
Eucatex SA Industria e Comercio
BOVESPA:EUCA4
|
BR |
|
Borosil Ltd
NSE:BOROLTD
|
IN |
|
Zhejiang Longsheng Group Co Ltd
SSE:600352
|
CN |
|
E
|
Eurobank Ergasias Services and Holdings SA
OTC:EGFEF
|
GR |
|
Rigaku Holdings Corp
TSE:268A
|
JP |
|
P
|
Pengana Capital Group Ltd
ASX:PCG
|
AU |
Field Trip Health Ltd
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptors. Its Field Trip Health division operates clinics across North America and Europe providing Ketamine-assisted psychotherapy (KAT) under various programs. Through its Field Trip Digital, it builds the digital and technological tools to support psychedelic experiences and consciousness expansion. The firm provides Trip and Portal applications. Its Trip is an iOS and Android application for consciousness expansion. Its Portal is a digital health platform for clients participating in psychedelic therapies at Field Trip Health centers.
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptors. Its Field Trip Health division operates clinics across North America and Europe providing Ketamine-assisted psychotherapy (KAT) under various programs. Through its Field Trip Digital, it builds the digital and technological tools to support psychedelic experiences and consciousness expansion. The firm provides Trip and Portal applications. Its Trip is an iOS and Android application for consciousness expansion. Its Portal is a digital health platform for clients participating in psychedelic therapies at Field Trip Health centers.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
